Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition.

Gong P, Deng F, Zhang W, Ji J, Liu J, Sun Y, Hu J.

Exp Ther Med. 2017 Nov;14(5):4431-4437. doi: 10.3892/etm.2017.5049. Epub 2017 Aug 28.

2.

Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.

Anusha C, Sumathi T, Joseph LD.

Chem Biol Interact. 2017 May 1;269:67-79. doi: 10.1016/j.cbi.2017.03.016. Epub 2017 Apr 4.

PMID:
28389404
3.
4.

Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models.

Ganesan P, Ko HM, Kim IS, Choi DK.

Int J Nanomedicine. 2015 Oct 29;10:6757-72. doi: 10.2147/IJN.S93918. eCollection 2015. Review.

6.

Investigating the role of Sirt1-modulated oxidative stress in relation to benign paroxysmal positional vertigo and Parkinson's disease.

Tsai KL, Cheng YY, Leu HB, Lee YY, Chen TJ, Liu DH, Kao CL.

Neurobiol Aging. 2015 Sep;36(9):2607-16. doi: 10.1016/j.neurobiolaging.2015.05.012. Epub 2015 Jun 4.

PMID:
26130063
7.

Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.

Sharma N, Nehru B.

Neurochem Int. 2015 Aug;87:92-105. doi: 10.1016/j.neuint.2015.06.004. Epub 2015 Jun 6.

PMID:
26055970
8.

The role of oxidative stress in Parkinson's disease.

Dias V, Junn E, Mouradian MM.

J Parkinsons Dis. 2013;3(4):461-91. doi: 10.3233/JPD-130230. Review.

9.

The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.

Niranjan R.

Mol Neurobiol. 2014 Feb;49(1):28-38. doi: 10.1007/s12035-013-8483-x. Epub 2013 Jun 20. Review.

PMID:
23783559
10.

Role of oxidative stress in Parkinson's disease.

Hwang O.

Exp Neurobiol. 2013 Mar;22(1):11-7. doi: 10.5607/en.2013.22.1.11. Epub 2013 Mar 31.

11.

Defective autophagy in Parkinson's disease: role of oxidative stress.

Janda E, Isidoro C, Carresi C, Mollace V.

Mol Neurobiol. 2012 Dec;46(3):639-61. doi: 10.1007/s12035-012-8318-1. Epub 2012 Aug 17. Review.

PMID:
22899187
12.

The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease.

Baillet A, Chanteperdrix V, Trocmé C, Casez P, Garrel C, Besson G.

Neurochem Res. 2010 Oct;35(10):1530-7. doi: 10.1007/s11064-010-0212-5. Epub 2010 Jun 10.

PMID:
20535556
13.

Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

Olivares D, Huang X, Branden L, Greig NH, Rogers JT.

Int J Mol Sci. 2009 Mar;10(3):1226-60. doi: 10.3390/ijms10031226. Epub 2009 Mar 17. Review.

14.
15.

Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.

Martignoni E, Blandini F, Godi L, Desideri S, Pacchetti C, Mancini F, Nappi G.

Free Radic Biol Med. 1999 Aug;27(3-4):428-37.

PMID:
10468218
16.

Oxidative stress: a role in the pathogenesis of Parkinson's disease.

Götz ME, Freyberger A, Riederer P.

J Neural Transm Suppl. 1990;29:241-9. Review.

PMID:
2193108

Supplemental Content

Loading ...
Support Center